Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Granulocyte transfusions in severe aplastic anemia.

Autor: Rajput RV; Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD. Roma.Rajput@nih.gov., Shah V; Hematology Consult and Graduate Medical Section, NHLBI, NIH, Bethesda, MD., Shalhoub RN; Office of Biostatistics Research, NHLBI, NIH, Bethesda, MD., West-Mitchell K; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Cha NR; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Conry-Cantilena C; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Leitman SF; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Young DJ; Translational Stem Cell Biology Branch, NHLBI, NIH, MD., Wells B; Laboratory of Transplantation Immunotherapy, NHLBI, NIH, Bethesda, MD., Aue G; Laboratory of Transplantation Immunotherapy, NHLBI, NIH, Bethesda, MD., Dunbar CE; Translational Stem Cell Biology Branch, NHLBI, NIH, MD., Patel BA; Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD., Childs RW; Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD., Young NS; Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD., Wu CO; Office of Biostatistics Research, NHLBI, NIH, Bethesda, MD., Groarke EM; Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD., Kalsi SS; Hematology Consult and Graduate Medical Section, NHLBI, NIH, Bethesda, MD.

Publikováno v: Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1792-1799. Date of Electronic Publication: 2024 Jun 01.

Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case.

Autor: Vannella KM; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Oguz C; National Institute of Allergy and Infectious Diseases Collaborative Bioinformatics Resource, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, United States.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, United States., Stein SR; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Dikoglu E; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Kanwal A; Division of Cardiology, Westchester Medical Center, Valhalla, NY, United States., Ramelli SC; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States., Briese T; Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, NY, United States., Su L; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, United States., Wu X; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, United States., Ramos-Benitez MJ; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.; Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, United States., Perez-Valencia LJ; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Babyak A; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Cha NR; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States., Chung JY; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Ylaya K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Madathil RJ; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD, United States., Saharia KK; Department of Medicine, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore, MD, United States., Scalea TM; Department of Surgery, Program in Trauma, R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, United States., Tran QK; Department of Emergency Medicine, R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, United States., Herr DL; Department of Medicine, Program in Trauma, R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, United States., Kleiner DE; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Hewitt SM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Grazioli A; Kidney Diseases Branch, Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States., Chertow DS; Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Dec 09; Vol. 12, pp. 779026. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2021).

The analysis of scalp irritation by coacervates produced in hair shampoo via FTIR with focal plane array detector, X-ray photoelectron microscopy and HaCaT cells.

Autor: Jung IK; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Park SC; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Kim SH; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Kim JH; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Cha NR; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Bae WR; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Kim HN; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Cho SA; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Yoo JW; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Kim BM; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea., Lee JH; AMOREPACIFIC Research and Development Center, 314-1 Bora-Dong, Yongin-Si, 446-729, South Korea.

Publikováno v: International journal of cosmetic science [Int J Cosmet Sci] 2017 Apr; Vol. 39 (2), pp. 149-155. Date of Electronic Publication: 2016 Sep 29.